The 1 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a -- increase from the last price of --.
The current consensus among 1 polled investment analysts is to Hold stock in Sinovac Biotech Ltd. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.08
Reporting Date Apr 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.